Issue 5, 2015

4-Methylcoumarins with cytotoxic activity against T24 and RT4 human bladder cancer cell lines

Abstract

Bladder cancer is one of the most prevalent malignancies of the genitourinary tract, and approximately 25% of patients develop superficial cancers with invasive and metastatic pathology. Coumarins and their derivatives have antiproliferative activity and induce apoptosis in several cancer cell lines. Due to the potential therapeutic applications of these compounds, a series of 4-methylcoumarins were synthesized to investigate the antitumor cytotoxic effect in the T24 and RT4 human bladder cancer cell lines. The microwave-assisted synthesis of the coumarinsvia Pechmann condensation with modifications at position 7 was performed with excellent yields (74–100%). The 7,8-dihydroxy-4-methyl-2-oxo-2H-chromene-5-carboxylic acid derivative (3c) exhibited greater cytotoxicity against T24 cells, which represent a more malignant cell line compared to RT4. In the T24 cells, cell cycle analysis revealed a large number of cells in the sub-G1 phase after treatment with 3c, which is indicative of apoptosis. Apoptotic death was confirmed by annexin V staining assay. Based on the chemical structures of the compounds, it is suggested that the 5-carboxycoumarin ring group has a positive influence on the cytotoxic activity. These results indicate that these new compounds are promising for further chemical modulation to discover a new antitumor agent.

Graphical abstract: 4-Methylcoumarins with cytotoxic activity against T24 and RT4 human bladder cancer cell lines

Article information

Article type
Concise Article
Submitted
28 Jan 2015
Accepted
25 Mar 2015
First published
26 Mar 2015

Med. Chem. Commun., 2015,6, 905-911

Author version available

4-Methylcoumarins with cytotoxic activity against T24 and RT4 human bladder cancer cell lines

D. R. Vianna, L. Ruschel, F. Dietrich, F. Figueiró, F. B. Morrone, R. F. S. Canto, F. Corvello, A. Velho, A. Crestani, H. Teixeira, G. L. von Poser, A. M. O. Battastini and V. L. Eifler-Lima, Med. Chem. Commun., 2015, 6, 905 DOI: 10.1039/C5MD00039D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements